000590 Stock Overview
Manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Tus-Pharmaceutical Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥5.49 |
| 52 Week High | CN¥11.25 |
| 52 Week Low | CN¥4.80 |
| Beta | 0.12 |
| 11 Month Change | 7.86% |
| 3 Month Change | -17.32% |
| 1 Year Change | -39.74% |
| 33 Year Change | -37.61% |
| 5 Year Change | -49.91% |
| Change since IPO | 37.53% |
Recent News & Updates
Shareholder Returns
| 000590 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 1.3% | 2.3% | -0.2% |
| 1Y | -39.7% | -11.1% | -19.8% |
Return vs Industry: 000590 underperformed the CN Pharmaceuticals industry which returned -11.1% over the past year.
Return vs Market: 000590 underperformed the CN Market which returned -19.8% over the past year.
Price Volatility
| 000590 volatility | |
|---|---|
| 000590 Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 5.2% |
| Market Average Movement | 5.6% |
| 10% most volatile stocks in CN Market | 9.0% |
| 10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 000590's share price has been volatile over the past 3 months.
Volatility Over Time: 000590's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1956 | 1,237 | Xue Feng | www.tuspharma.cn |
Tus-Pharmaceutical Group Co., Ltd. manufactures and sells Chinese patent medicines, chemical medicines, and health foods in China. The company offers Guhan health essences, Danzao oral liquids, Danhuang granules, and Yangxin Dingpalan granules. It also provides tonic health care, cardiovascular and cerebrovascular products, children's nutrition, cold products, heat-clearing, and detoxification products, etc. The company was formerly known as Tus-Guhan Group Corp.,Ltd.
Tus-Pharmaceutical Group Co., Ltd. Fundamentals Summary
| 000590 fundamental statistics | |
|---|---|
| Market cap | CN¥1.31b |
| Earnings (TTM) | CN¥10.38m |
| Revenue (TTM) | CN¥380.54m |
126.7x
P/E Ratio3.5x
P/S RatioIs 000590 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000590 income statement (TTM) | |
|---|---|
| Revenue | CN¥380.54m |
| Cost of Revenue | CN¥184.08m |
| Gross Profit | CN¥196.46m |
| Other Expenses | CN¥186.08m |
| Earnings | CN¥10.38m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 29, 2024
| Earnings per share (EPS) | 0.043 |
| Gross Margin | 51.63% |
| Net Profit Margin | 2.73% |
| Debt/Equity Ratio | 16.3% |
How did 000590 perform over the long term?
See historical performance and comparison